Strategic Partners & Stakeholders
ASMO has strategic partnerships with the Ministry of Public Health (MoPH), local manufacturers, importers, international suppliers, creative media agencies for advertising and education, distributions and supply chain partners and local NGOs providing outreach communication, training and evaluation services. It also strongly supports the private commercial sector through funding and capacity building activities to several professional associations and local suppliers. ASMO continues to pursue broader collaborations with relevant ministries within the Government of the Islamic Republic of Afghanistan, other donors, local and international organizations.
Under HPP and with a sub-contract with Futures Group International, ASMO continues to increase demand for, access to, and use of birth spacing and child survival health products to the Afghan population, especially women of reproductive age and children under the age of five through innovative and culturally appropriate social marketing and BCC strategies. The comprehensive and integrated social marketing programs utilized by the Project includes targeted research on the private sector market; distribution; pharmaceutical quality improvement in management and commodities productions; innovative behavioral change communications; and public-private sector activities.
The Health Policy Project (HPP) aims to strengthen developing country national and sub national policy, advocacy, and governance for strategic, equitable, and sustainable health programming. The project, funded by the United States Agency for International Development (USAID), addresses key health issues—family planning/reproductive health (FP/RH), HIV, and maternal health—and promotes health systems strengthening and program integration.
HPP will build capacity of governments, civil society, and other in-country partners to advocate for, manage, and finance their health programs. Doing so will help ensuring that host countries are at the center of decision making and leadership for their health programs, as envisioned in the sustainability objectives of the U.S. Government’s Global Health Initiative and President’s Emergency Plan for AIDS Relief (PEPFAR).
Futures Group International is currently registered in Afghanistan as an international NGO based in Washington, D.C. Having implemented projects in more than 100 countries, Futures Group is a global leader in designing and executing effective programs and strategies to address critical public health issues, including family planning and reproductive health, HIV and AIDS, maternal and child health and infectious diseases. Futures Group specializes in helping countries and communities build local capacity and forge effective public-private partnerships. Using this approach, partners become better-equipped to make well-informed decisions and address a multitude of complex health and social issues. Futures Group works together with numerous government agencies, local and international donors, charities, foundations, corporations, and NGOs to address conditions that compromise the well-being of people around the world.
The Project continues to procure its contraceptive products from USAID-funded international suppliers. However, de-hydration and safe water products are being sourced locally from Khalid Irshad Pharmaceuticals (KIP). Khalid Irshad Pharmaceutical (Pvt) Ltd was established in 2002 and officially inaugurated by the former Minister of the Public Health with the aim of rebuilding the local health product supplier and quality pharmaceutical production capabilities infrastructure within Afghanistan.
In response to the need to find a local source of quality affordable chlorinated water treatment solutions and after a review of all available and licensed pharmaceutical companies within Afghanistan, USAID through its original social marketing contractor chose Khalid Irshad Pharmaceuticals to produce the chlorinated water treatment solution then known and branded as Abpakon.
In February 2008, the Project awarded a grant to KIP using USAID funds to procure “state of the art” diagnostic quality control equipment as specified by the CDC in Atlanta, Georgia USA. This allowed KIP to verify the quality of all incoming raw materials, in-process production and final finished product performance against the training and criteria provided by the CDC. In addition, this new quality control equipment granted to KIP by USAID allowed our pharmaceutical partner to begin to produce locally three (3) flavors of Shefa brand Oral Rehydration Salts that were previously procured and sourced from India.
And finally, the COMPRI-A Project has supported Khalid Irshad Pharmaceuticals in collaboration with an international recognized certification body from India to obtain ISO 9001:2008 certifications for its facility by the end of February 2009. When this happened, KIP became the first ISO certified pharmaceutical company in the commercial history of Afghanistan. This certification has been thoroughly documented for dissemination to and discussions with other local Afghan Pharmaceutical companies in order to help increase the quality of local pharmaceutical product suppliers to internationally acceptable levels.